Jefferies Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $17
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Glen Santangelo has initiated coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and set a price target of $17.

December 19, 2023 | 4:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Glen Santangelo initiated coverage on Elanco Animal Health with a Buy rating and a price target of $17, which could positively influence the stock's performance in the short term.
Analyst ratings, especially from reputable firms like Jefferies, can significantly impact a stock's performance in the short term. A Buy rating suggests that the analyst sees potential in the company's future performance, which can lead to increased investor confidence and a potential rise in the stock price. The announcement of a price target provides a specific goal that can influence investor expectations and trading behavior.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100